| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Hypertrophic | 125 | 2023 | 1265 | 11.090 |
Why?
|
| Sarcomeres | 48 | 2022 | 374 | 7.350 |
Why?
|
| Cardiomyopathy, Dilated | 54 | 2023 | 851 | 6.320 |
Why?
|
| Myocytes, Cardiac | 44 | 2024 | 1629 | 3.290 |
Why?
|
| Myosin Heavy Chains | 38 | 2022 | 414 | 3.240 |
Why?
|
| Cardiomyopathies | 32 | 2023 | 1912 | 3.150 |
Why?
|
| Heart Defects, Congenital | 43 | 2024 | 4583 | 3.090 |
Why?
|
| Induced Pluripotent Stem Cells | 19 | 2024 | 1736 | 2.650 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 15 | 2018 | 66 | 2.580 |
Why?
|
| Mutation | 147 | 2024 | 29786 | 2.440 |
Why?
|
| Mutation, Missense | 43 | 2023 | 2566 | 2.430 |
Why?
|
| Myocardium | 85 | 2023 | 4772 | 2.260 |
Why?
|
| Muscle Proteins | 20 | 2022 | 1158 | 1.970 |
Why?
|
| Cardiac Myosins | 10 | 2020 | 117 | 1.810 |
Why?
|
| Myosins | 24 | 2019 | 409 | 1.750 |
Why?
|
| Myocardial Contraction | 32 | 2021 | 1579 | 1.730 |
Why?
|
| T-Box Domain Proteins | 16 | 2022 | 471 | 1.550 |
Why?
|
| Carrier Proteins | 35 | 2022 | 5023 | 1.530 |
Why?
|
| Pedigree | 81 | 2023 | 4642 | 1.520 |
Why?
|
| Hypertrophy, Left Ventricular | 19 | 2023 | 857 | 1.470 |
Why?
|
| Genetic Testing | 27 | 2023 | 3444 | 1.420 |
Why?
|
| Genetic Variation | 27 | 2021 | 6542 | 1.360 |
Why?
|
| Chagas Disease | 4 | 2023 | 166 | 1.330 |
Why?
|
| Trypanosoma cruzi | 4 | 2023 | 197 | 1.320 |
Why?
|
| Heart Ventricles | 36 | 2023 | 3817 | 1.290 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2023 | 71 | 1.270 |
Why?
|
| Cardiomegaly | 16 | 2023 | 620 | 1.240 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 5 | 2022 | 161 | 1.210 |
Why?
|
| Genetic Predisposition to Disease | 51 | 2023 | 17446 | 1.190 |
Why?
|
| Heart | 38 | 2023 | 4464 | 1.180 |
Why?
|
| Genes, Dominant | 22 | 2019 | 880 | 1.150 |
Why?
|
| Calcium-Binding Proteins | 11 | 2020 | 1081 | 1.130 |
Why?
|
| Heterozygote | 29 | 2021 | 2804 | 1.110 |
Why?
|
| Phenotype | 77 | 2023 | 16367 | 1.100 |
Why?
|
| Glycogen Storage Disease Type IIb | 5 | 2023 | 18 | 1.080 |
Why?
|
| Homeodomain Proteins | 20 | 2016 | 2418 | 1.060 |
Why?
|
| Haploinsufficiency | 8 | 2021 | 328 | 1.040 |
Why?
|
| Ventricular Myosins | 12 | 2018 | 50 | 1.030 |
Why?
|
| Troponin I | 11 | 2022 | 619 | 1.000 |
Why?
|
| Protein Kinases | 6 | 2022 | 1640 | 0.980 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 4 | 2021 | 52 | 0.970 |
Why?
|
| Genomics | 14 | 2023 | 5717 | 0.950 |
Why?
|
| Atrial Natriuretic Factor | 21 | 2012 | 393 | 0.910 |
Why?
|
| Calcium | 37 | 2021 | 5755 | 0.910 |
Why?
|
| Sequence Analysis, RNA | 13 | 2022 | 2012 | 0.890 |
Why?
|
| Micrognathism | 1 | 2022 | 57 | 0.860 |
Why?
|
| Goldenhar Syndrome | 1 | 2022 | 37 | 0.850 |
Why?
|
| RNA Splicing | 9 | 2023 | 908 | 0.830 |
Why?
|
| Hearing Loss, Sensorineural | 11 | 2010 | 770 | 0.830 |
Why?
|
| Mice | 147 | 2024 | 81201 | 0.820 |
Why?
|
| Gene Expression Regulation, Developmental | 13 | 2018 | 3617 | 0.810 |
Why?
|
| Humans | 366 | 2024 | 744366 | 0.800 |
Why?
|
| Genetic Linkage | 30 | 2015 | 2421 | 0.790 |
Why?
|
| Single-Cell Analysis | 3 | 2022 | 2182 | 0.770 |
Why?
|
| Sequence Analysis, DNA | 19 | 2018 | 4805 | 0.770 |
Why?
|
| Animals | 201 | 2024 | 168768 | 0.760 |
Why?
|
| Troponin T | 15 | 2022 | 754 | 0.740 |
Why?
|
| Genetic Heterogeneity | 6 | 2014 | 733 | 0.740 |
Why?
|
| Chromosome Mapping | 37 | 2018 | 4740 | 0.730 |
Why?
|
| Multienzyme Complexes | 12 | 2008 | 686 | 0.730 |
Why?
|
| Transcription Factors | 29 | 2022 | 12207 | 0.720 |
Why?
|
| Genetics | 2 | 2020 | 112 | 0.720 |
Why?
|
| Heart Failure | 23 | 2023 | 10895 | 0.710 |
Why?
|
| AMP-Activated Protein Kinases | 13 | 2016 | 610 | 0.710 |
Why?
|
| Benzylamines | 3 | 2019 | 223 | 0.700 |
Why?
|
| DNA Copy Number Variations | 5 | 2023 | 1941 | 0.700 |
Why?
|
| Uracil | 3 | 2019 | 165 | 0.700 |
Why?
|
| RNA | 8 | 2023 | 2749 | 0.690 |
Why?
|
| Fibrosis | 15 | 2023 | 2029 | 0.670 |
Why?
|
| Point Mutation | 15 | 2020 | 1624 | 0.670 |
Why?
|
| Sendai virus | 1 | 2018 | 21 | 0.650 |
Why?
|
| Ear | 2 | 2022 | 173 | 0.640 |
Why?
|
| Genotype | 42 | 2023 | 12952 | 0.630 |
Why?
|
| Genetic Vectors | 6 | 2018 | 3424 | 0.620 |
Why?
|
| Cardiovascular System | 3 | 2022 | 831 | 0.610 |
Why?
|
| DNA, Mitochondrial | 3 | 2022 | 817 | 0.610 |
Why?
|
| Heart Diseases | 5 | 2022 | 2789 | 0.590 |
Why?
|
| Chromosomes, Human, Pair 15 | 6 | 2020 | 373 | 0.590 |
Why?
|
| Echocardiography | 30 | 2021 | 5099 | 0.580 |
Why?
|
| Cardiovascular Agents | 3 | 2019 | 850 | 0.580 |
Why?
|
| Calcium Channel Blockers | 4 | 2014 | 692 | 0.560 |
Why?
|
| Diltiazem | 3 | 2014 | 133 | 0.560 |
Why?
|
| GATA4 Transcription Factor | 2 | 2022 | 131 | 0.560 |
Why?
|
| Male | 210 | 2023 | 350115 | 0.550 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2018 | 3595 | 0.550 |
Why?
|
| Gene Dosage | 4 | 2020 | 1252 | 0.550 |
Why?
|
| Virus Integration | 1 | 2018 | 299 | 0.550 |
Why?
|
| Disease Models, Animal | 44 | 2022 | 18034 | 0.550 |
Why?
|
| Adenosine Triphosphatases | 3 | 2020 | 839 | 0.540 |
Why?
|
| Blood Cells | 1 | 2018 | 309 | 0.540 |
Why?
|
| Calcium Channels | 2 | 2017 | 622 | 0.530 |
Why?
|
| Tropomyosin | 8 | 2010 | 102 | 0.530 |
Why?
|
| Tetralogy of Fallot | 2 | 2012 | 623 | 0.520 |
Why?
|
| Genetics, Medical | 2 | 2013 | 338 | 0.520 |
Why?
|
| Founder Effect | 4 | 2022 | 189 | 0.520 |
Why?
|
| Contractile Proteins | 3 | 2012 | 246 | 0.520 |
Why?
|
| Arrhythmias, Cardiac | 14 | 2021 | 2269 | 0.520 |
Why?
|
| DNA Mutational Analysis | 27 | 2018 | 4185 | 0.520 |
Why?
|
| Aortic Valve | 5 | 2019 | 1924 | 0.520 |
Why?
|
| Gene Regulatory Networks | 7 | 2022 | 1707 | 0.510 |
Why?
|
| Ventricular Dysfunction | 3 | 2011 | 143 | 0.510 |
Why?
|
| Molecular Sequence Data | 54 | 2014 | 18111 | 0.500 |
Why?
|
| Gene Expression Profiling | 14 | 2020 | 9445 | 0.500 |
Why?
|
| Sequence Deletion | 8 | 2018 | 1525 | 0.500 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2014 | 17 | 0.490 |
Why?
|
| Genome, Human | 10 | 2020 | 4420 | 0.490 |
Why?
|
| Female | 187 | 2023 | 380193 | 0.480 |
Why?
|
| Cytokinesis | 1 | 2015 | 177 | 0.470 |
Why?
|
| Glycogen Storage Disease | 5 | 2007 | 41 | 0.470 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2017 | 644 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 3 | 4 | 2020 | 323 | 0.460 |
Why?
|
| Gene Expression Regulation | 26 | 2021 | 12073 | 0.460 |
Why?
|
| Adult | 123 | 2024 | 214052 | 0.460 |
Why?
|
| Death, Sudden, Cardiac | 12 | 2020 | 1541 | 0.460 |
Why?
|
| Calsequestrin | 6 | 2014 | 30 | 0.450 |
Why?
|
| Software | 7 | 2020 | 4441 | 0.450 |
Why?
|
| Cardiology | 3 | 2022 | 1668 | 0.450 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2017 | 234 | 0.440 |
Why?
|
| Genetic Counseling | 7 | 2018 | 600 | 0.440 |
Why?
|
| Fetal Development | 1 | 2018 | 767 | 0.430 |
Why?
|
| Child | 55 | 2023 | 77709 | 0.430 |
Why?
|
| Ubiquitins | 1 | 2014 | 384 | 0.420 |
Why?
|
| Models, Cardiovascular | 5 | 2013 | 996 | 0.420 |
Why?
|
| Adolescent | 65 | 2023 | 85779 | 0.410 |
Why?
|
| Plasmids | 3 | 2001 | 2308 | 0.400 |
Why?
|
| Homozygote | 13 | 2017 | 1787 | 0.400 |
Why?
|
| Penetrance | 8 | 2020 | 381 | 0.400 |
Why?
|
| Congenital Abnormalities | 4 | 2015 | 707 | 0.400 |
Why?
|
| Apolipoproteins | 1 | 2013 | 317 | 0.400 |
Why?
|
| Abnormalities, Multiple | 8 | 2020 | 1416 | 0.400 |
Why?
|
| Transformation, Bacterial | 2 | 2001 | 78 | 0.400 |
Why?
|
| Heart Conduction System | 8 | 2017 | 1047 | 0.390 |
Why?
|
| Base Sequence | 39 | 2018 | 12797 | 0.380 |
Why?
|
| Syndrome | 18 | 2013 | 3252 | 0.380 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2010 | 106 | 0.370 |
Why?
|
| Trans-Activators | 6 | 2013 | 2926 | 0.370 |
Why?
|
| Amino Acid Sequence | 39 | 2013 | 13814 | 0.370 |
Why?
|
| Smad4 Protein | 1 | 2011 | 163 | 0.370 |
Why?
|
| Verapamil | 5 | 2019 | 244 | 0.360 |
Why?
|
| Procollagen | 1 | 2010 | 185 | 0.360 |
Why?
|
| Pericardium | 5 | 2018 | 667 | 0.360 |
Why?
|
| Middle Aged | 94 | 2021 | 213390 | 0.350 |
Why?
|
| Epigenesis, Genetic | 7 | 2023 | 3646 | 0.350 |
Why?
|
| Child, Preschool | 30 | 2021 | 41005 | 0.350 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 638 | 0.340 |
Why?
|
| Biomedical Research | 3 | 2020 | 3309 | 0.340 |
Why?
|
| Mice, Mutant Strains | 19 | 2017 | 1865 | 0.340 |
Why?
|
| Heart Valves | 1 | 2011 | 291 | 0.340 |
Why?
|
| Peripartum Period | 3 | 2021 | 133 | 0.330 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2009 | 1375 | 0.330 |
Why?
|
| Glycogen | 6 | 2016 | 259 | 0.330 |
Why?
|
| Cell Differentiation | 9 | 2020 | 11486 | 0.330 |
Why?
|
| Ventricular Remodeling | 7 | 2023 | 1223 | 0.330 |
Why?
|
| Plakophilins | 2 | 2022 | 34 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 14 | 6 | 2000 | 299 | 0.330 |
Why?
|
| Electrocardiography | 24 | 2020 | 6442 | 0.320 |
Why?
|
| Age of Onset | 13 | 2020 | 3270 | 0.320 |
Why?
|
| Mice, Transgenic | 30 | 2019 | 9735 | 0.320 |
Why?
|
| Cloning, Molecular | 12 | 2001 | 4320 | 0.320 |
Why?
|
| Myocardial Ischemia | 5 | 2019 | 2148 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 1 | 6 | 2009 | 658 | 0.310 |
Why?
|
| Cardiovascular Diseases | 11 | 2021 | 15160 | 0.310 |
Why?
|
| Coronary Artery Bypass | 4 | 2019 | 2288 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 2 | 3 | 1999 | 326 | 0.310 |
Why?
|
| Models, Genetic | 6 | 2019 | 3493 | 0.310 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2007 | 34 | 0.300 |
Why?
|
| Alleles | 17 | 2020 | 6933 | 0.300 |
Why?
|
| Myofibrils | 4 | 2017 | 146 | 0.300 |
Why?
|
| Neoplasms | 4 | 2022 | 21696 | 0.300 |
Why?
|
| American Heart Association | 6 | 2017 | 1057 | 0.300 |
Why?
|
| Calcium Signaling | 6 | 2021 | 721 | 0.300 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 13693 | 0.300 |
Why?
|
| Haplotypes | 15 | 2020 | 2779 | 0.300 |
Why?
|
| Electron Transport Complex III | 1 | 2007 | 31 | 0.300 |
Why?
|
| Computational Biology | 3 | 2018 | 3519 | 0.300 |
Why?
|
| Gene Frequency | 6 | 2023 | 3587 | 0.290 |
Why?
|
| Xenopus Proteins | 5 | 2002 | 433 | 0.290 |
Why?
|
| Zebrafish | 4 | 2018 | 2996 | 0.290 |
Why?
|
| Twins, Monozygotic | 3 | 2021 | 458 | 0.290 |
Why?
|
| Amino Acid Substitution | 12 | 2014 | 1793 | 0.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2023 | 2917 | 0.290 |
Why?
|
| Young Adult | 35 | 2023 | 56429 | 0.290 |
Why?
|
| Troponin | 7 | 2010 | 524 | 0.290 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2018 | 850 | 0.280 |
Why?
|
| Hair Diseases | 1 | 2007 | 74 | 0.280 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2018 | 713 | 0.280 |
Why?
|
| Cells, Cultured | 18 | 2021 | 19233 | 0.270 |
Why?
|
| Dependovirus | 3 | 2016 | 706 | 0.270 |
Why?
|
| Proteins | 8 | 2024 | 6100 | 0.270 |
Why?
|
| Fluorescence | 2 | 2019 | 751 | 0.270 |
Why?
|
| Hearing Loss | 1 | 2013 | 765 | 0.270 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2008 | 494 | 0.270 |
Why?
|
| Tachycardia, Ventricular | 9 | 2014 | 1273 | 0.270 |
Why?
|
| Lod Score | 13 | 2006 | 614 | 0.270 |
Why?
|
| Polymorphism, Genetic | 14 | 2020 | 4328 | 0.260 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2024 | 142 | 0.260 |
Why?
|
| Zebrafish Proteins | 3 | 2016 | 1005 | 0.260 |
Why?
|
| Heart Arrest, Induced | 2 | 2018 | 355 | 0.260 |
Why?
|
| DNA | 20 | 2011 | 7294 | 0.250 |
Why?
|
| Infant | 18 | 2022 | 35134 | 0.250 |
Why?
|
| History, 21st Century | 4 | 2021 | 1534 | 0.250 |
Why?
|
| Propranolol | 3 | 2019 | 502 | 0.250 |
Why?
|
| Lamin Type A | 4 | 2017 | 190 | 0.250 |
Why?
|
| Histones | 4 | 2023 | 2598 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 22 | 2020 | 21833 | 0.250 |
Why?
|
| History, 20th Century | 5 | 2021 | 2740 | 0.250 |
Why?
|
| Mice, Knockout | 28 | 2020 | 14561 | 0.250 |
Why?
|
| Anodontia | 3 | 2003 | 49 | 0.250 |
Why?
|
| Aged | 57 | 2021 | 163288 | 0.250 |
Why?
|
| RNA Interference | 1 | 2013 | 2890 | 0.250 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 4 | 2010 | 175 | 0.250 |
Why?
|
| Ventricular Function, Left | 8 | 2020 | 3666 | 0.240 |
Why?
|
| Transformation, Genetic | 2 | 2002 | 192 | 0.240 |
Why?
|
| Ear, Inner | 1 | 2008 | 420 | 0.240 |
Why?
|
| Heart Atria | 9 | 2020 | 1356 | 0.240 |
Why?
|
| Energy Metabolism | 10 | 2020 | 2897 | 0.240 |
Why?
|
| Genome-Wide Association Study | 11 | 2022 | 12262 | 0.240 |
Why?
|
| Ear, External | 3 | 2022 | 161 | 0.240 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 195 | 0.240 |
Why?
|
| Adenosine Triphosphate | 5 | 2019 | 2027 | 0.240 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2016 | 2839 | 0.240 |
Why?
|
| Cell Cycle Proteins | 2 | 2014 | 3464 | 0.240 |
Why?
|
| Heart Septal Defects, Atrial | 4 | 2002 | 478 | 0.230 |
Why?
|
| Genes, Recessive | 2 | 2019 | 641 | 0.230 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 22 | 0.230 |
Why?
|
| Endothelial Cells | 4 | 2024 | 3486 | 0.230 |
Why?
|
| Heart Transplantation | 5 | 2023 | 3112 | 0.230 |
Why?
|
| Algorithms | 5 | 2021 | 13882 | 0.230 |
Why?
|
| Cell Nucleus | 3 | 2022 | 2969 | 0.230 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5749 | 0.220 |
Why?
|
| Homeostasis | 9 | 2020 | 3339 | 0.220 |
Why?
|
| Trypan Blue | 1 | 2022 | 21 | 0.220 |
Why?
|
| Nuclear Proteins | 6 | 2022 | 5856 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 17 | 2021 | 15520 | 0.220 |
Why?
|
| Exons | 7 | 2021 | 2439 | 0.220 |
Why?
|
| Stress, Physiological | 3 | 2018 | 1403 | 0.220 |
Why?
|
| Molecular Biology | 3 | 2018 | 596 | 0.210 |
Why?
|
| Pyoderma Gangrenosum | 3 | 2002 | 76 | 0.210 |
Why?
|
| Microscopy, Fluorescence | 3 | 2021 | 2700 | 0.210 |
Why?
|
| Atherosclerosis | 2 | 2021 | 3444 | 0.210 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2022 | 76 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2009 | 374 | 0.210 |
Why?
|
| Hand Deformities, Congenital | 2 | 2012 | 146 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2023 | 1862 | 0.210 |
Why?
|
| Dystrophin | 1 | 2023 | 285 | 0.210 |
Why?
|
| DNA, Recombinant | 2 | 2001 | 476 | 0.210 |
Why?
|
| Sucrose | 1 | 2022 | 164 | 0.210 |
Why?
|
| Genes | 8 | 2009 | 1893 | 0.210 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2002 | 29 | 0.200 |
Why?
|
| Research | 1 | 2010 | 1999 | 0.200 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2024 | 794 | 0.200 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 4 | 2019 | 126 | 0.200 |
Why?
|
| Signal Transduction | 15 | 2019 | 23404 | 0.200 |
Why?
|
| Sex Characteristics | 5 | 2020 | 2585 | 0.200 |
Why?
|
| Animals, Newborn | 9 | 2018 | 2726 | 0.200 |
Why?
|
| Infant, Newborn | 13 | 2022 | 25628 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2006 | 322 | 0.200 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2016 | 500 | 0.200 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2023 | 1157 | 0.200 |
Why?
|
| Rats | 26 | 2019 | 24252 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2008 | 197 | 0.200 |
Why?
|
| Genetic Association Studies | 7 | 2020 | 2703 | 0.200 |
Why?
|
| Wolff-Parkinson-White Syndrome | 4 | 2003 | 117 | 0.190 |
Why?
|
| Atlases as Topic | 1 | 2022 | 236 | 0.190 |
Why?
|
| Solitary Nucleus | 1 | 2021 | 63 | 0.190 |
Why?
|
| Transcription, Genetic | 11 | 2020 | 7721 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2010 | 2073 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 4 | 2023 | 2007 | 0.190 |
Why?
|
| Peptide Fragments | 4 | 2010 | 5096 | 0.190 |
Why?
|
| GATA6 Transcription Factor | 1 | 2020 | 50 | 0.190 |
Why?
|
| Muscle Cells | 2 | 2016 | 197 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2000 | 380 | 0.190 |
Why?
|
| Hyperparathyroidism | 4 | 1996 | 339 | 0.180 |
Why?
|
| Arthritis | 3 | 2002 | 661 | 0.180 |
Why?
|
| Diastole | 4 | 2018 | 791 | 0.180 |
Why?
|
| Case-Control Studies | 14 | 2021 | 21748 | 0.180 |
Why?
|
| Microscopy, Atomic Force | 2 | 2019 | 250 | 0.180 |
Why?
|
| Urea | 2 | 2019 | 450 | 0.180 |
Why?
|
| Heart Rate | 9 | 2016 | 4092 | 0.180 |
Why?
|
| Avian Proteins | 2 | 1999 | 80 | 0.180 |
Why?
|
| Anthracyclines | 1 | 2022 | 288 | 0.180 |
Why?
|
| Heart Septum | 2 | 2020 | 312 | 0.180 |
Why?
|
| Heart Failure, Systolic | 1 | 2021 | 126 | 0.180 |
Why?
|
| Lysosomes | 2 | 2023 | 893 | 0.180 |
Why?
|
| Muscle Relaxation | 1 | 2020 | 142 | 0.180 |
Why?
|
| Transcription Factor TFIID | 1 | 2020 | 151 | 0.180 |
Why?
|
| Electroporation | 1 | 2001 | 251 | 0.170 |
Why?
|
| Oxidoreductases | 1 | 2022 | 424 | 0.170 |
Why?
|
| Potassium Channels | 3 | 2017 | 563 | 0.170 |
Why?
|
| Complement C4 | 1 | 2020 | 257 | 0.170 |
Why?
|
| Receptors, Adrenergic, alpha | 4 | 2014 | 149 | 0.170 |
Why?
|
| YY1 Transcription Factor | 1 | 2019 | 60 | 0.170 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2020 | 104 | 0.170 |
Why?
|
| DNA, Complementary | 9 | 2022 | 2050 | 0.170 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2019 | 96 | 0.170 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2019 | 112 | 0.170 |
Why?
|
| Cell Proliferation | 6 | 2019 | 10483 | 0.170 |
Why?
|
| Mice, Inbred Strains | 6 | 2016 | 1828 | 0.170 |
Why?
|
| Hypercalcemia | 4 | 1996 | 409 | 0.170 |
Why?
|
| Paternal Age | 1 | 2019 | 84 | 0.170 |
Why?
|
| Aging | 6 | 2023 | 8664 | 0.170 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 376 | 0.170 |
Why?
|
| Acne Vulgaris | 3 | 2002 | 302 | 0.170 |
Why?
|
| DNA Primers | 12 | 2009 | 2891 | 0.170 |
Why?
|
| Extremities | 2 | 2024 | 866 | 0.170 |
Why?
|
| Sinoatrial Node | 2 | 2018 | 101 | 0.170 |
Why?
|
| Systole | 6 | 2019 | 958 | 0.170 |
Why?
|
| Angiotensin II | 2 | 2023 | 881 | 0.170 |
Why?
|
| Diaphragm | 1 | 2020 | 349 | 0.170 |
Why?
|
| Cerebrum | 1 | 2020 | 137 | 0.160 |
Why?
|
| Mosaicism | 2 | 2020 | 441 | 0.160 |
Why?
|
| Online Systems | 1 | 2019 | 184 | 0.160 |
Why?
|
| Serum Response Factor | 1 | 2018 | 81 | 0.160 |
Why?
|
| Phosphorylation | 8 | 2015 | 8436 | 0.160 |
Why?
|
| X Chromosome | 3 | 1999 | 814 | 0.160 |
Why?
|
| Intracranial Aneurysm | 3 | 2016 | 1197 | 0.160 |
Why?
|
| Activin Receptors, Type II | 1 | 2019 | 127 | 0.160 |
Why?
|
| Sjogren's Syndrome | 1 | 2020 | 234 | 0.160 |
Why?
|
| Cell-Matrix Junctions | 1 | 2018 | 23 | 0.160 |
Why?
|
| Atrial Fibrillation | 9 | 2020 | 5035 | 0.160 |
Why?
|
| Mitochondria | 4 | 2022 | 3514 | 0.160 |
Why?
|
| Azepines | 1 | 2020 | 334 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.160 |
Why?
|
| Angiotensin Amide | 1 | 2017 | 4 | 0.160 |
Why?
|
| RNA, Messenger | 23 | 2020 | 13035 | 0.160 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 335 | 0.160 |
Why?
|
| Fabry Disease | 2 | 2017 | 90 | 0.160 |
Why?
|
| Bromodeoxyuridine | 2 | 2016 | 322 | 0.160 |
Why?
|
| Growth Differentiation Factor 1 | 1 | 2017 | 6 | 0.160 |
Why?
|
| Sequence Alignment | 8 | 2013 | 2256 | 0.160 |
Why?
|
| Complement C3 | 1 | 2020 | 461 | 0.160 |
Why?
|
| Cell Separation | 4 | 2021 | 1751 | 0.160 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 136 | 0.160 |
Why?
|
| Hypophosphatemia, Familial | 1 | 1998 | 34 | 0.160 |
Why?
|
| Protein Biosynthesis | 5 | 2019 | 2126 | 0.150 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2011 | 476 | 0.150 |
Why?
|
| Interleukin-11 | 1 | 2017 | 63 | 0.150 |
Why?
|
| In Situ Hybridization | 7 | 2013 | 1950 | 0.150 |
Why?
|
| JC Virus | 1 | 2018 | 85 | 0.150 |
Why?
|
| Embryo, Nonmammalian | 4 | 2018 | 895 | 0.150 |
Why?
|
| Aged, 80 and over | 20 | 2021 | 57776 | 0.150 |
Why?
|
| Proteoglycans | 3 | 2016 | 837 | 0.150 |
Why?
|
| Cohort Studies | 15 | 2020 | 40559 | 0.150 |
Why?
|
| Computer-Aided Design | 1 | 2019 | 298 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2017 | 118 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 1997 | 462 | 0.150 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 409 | 0.150 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2016 | 314 | 0.150 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 1997 | 798 | 0.150 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2010 | 789 | 0.140 |
Why?
|
| Actinin | 1 | 2018 | 160 | 0.140 |
Why?
|
| Mitochondria, Liver | 1 | 2017 | 187 | 0.140 |
Why?
|
| Arm | 2 | 1997 | 589 | 0.140 |
Why?
|
| Autophagy | 2 | 2022 | 1297 | 0.140 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 134 | 0.140 |
Why?
|
| RNA, Untranslated | 1 | 2020 | 453 | 0.140 |
Why?
|
| Chloride Channels | 1 | 1998 | 227 | 0.140 |
Why?
|
| Molecular Motor Proteins | 2 | 2007 | 107 | 0.140 |
Why?
|
| Face | 1 | 2022 | 994 | 0.140 |
Why?
|
| Gene Transfer Techniques | 2 | 2001 | 1225 | 0.140 |
Why?
|
| CpG Islands | 1 | 2020 | 1170 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 11 | 2011 | 6171 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1996 | 133 | 0.140 |
Why?
|
| DNA, Bacterial | 1 | 2001 | 1465 | 0.140 |
Why?
|
| Fibroblasts | 4 | 2024 | 4162 | 0.140 |
Why?
|
| Thrombospondins | 1 | 2016 | 198 | 0.140 |
Why?
|
| Proteomics | 4 | 2023 | 3638 | 0.140 |
Why?
|
| Prevalence | 9 | 2022 | 15221 | 0.130 |
Why?
|
| Models, Biological | 6 | 2020 | 9584 | 0.130 |
Why?
|
| Investments | 1 | 2017 | 143 | 0.130 |
Why?
|
| Gene Expression | 11 | 2019 | 7798 | 0.130 |
Why?
|
| Deafness | 1 | 2000 | 458 | 0.130 |
Why?
|
| Protein Conformation | 4 | 2020 | 4010 | 0.130 |
Why?
|
| Myosin Subfragments | 3 | 1997 | 21 | 0.130 |
Why?
|
| Receptors, Cell Surface | 9 | 2009 | 2865 | 0.130 |
Why?
|
| Isoproterenol | 1 | 2015 | 399 | 0.130 |
Why?
|
| Mutant Proteins | 2 | 2015 | 500 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 944 | 0.130 |
Why?
|
| Lidocaine | 1 | 2018 | 544 | 0.130 |
Why?
|
| Electrophysiology | 9 | 2007 | 1308 | 0.130 |
Why?
|
| Chromatin | 6 | 2023 | 2933 | 0.130 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2018 | 964 | 0.130 |
Why?
|
| Heart Block | 5 | 2016 | 410 | 0.130 |
Why?
|
| Disease Progression | 10 | 2018 | 13286 | 0.130 |
Why?
|
| Codon | 5 | 2019 | 611 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 513 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 7 | 2014 | 5867 | 0.120 |
Why?
|
| Consanguinity | 2 | 2015 | 454 | 0.120 |
Why?
|
| HEK293 Cells | 4 | 2019 | 4208 | 0.120 |
Why?
|
| Triazoles | 1 | 2020 | 908 | 0.120 |
Why?
|
| Morphogenesis | 2 | 2011 | 751 | 0.120 |
Why?
|
| Aorta, Abdominal | 1 | 2017 | 646 | 0.120 |
Why?
|
| Affinity Labels | 2 | 1984 | 109 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1995 | 417 | 0.120 |
Why?
|
| Molecular Probe Techniques | 2 | 2011 | 119 | 0.120 |
Why?
|
| Losartan | 2 | 2013 | 299 | 0.120 |
Why?
|
| Defibrillators, Implantable | 3 | 2020 | 1440 | 0.120 |
Why?
|
| DNA-Binding Proteins | 7 | 2019 | 9647 | 0.120 |
Why?
|
| Blotting, Northern | 7 | 2009 | 1581 | 0.120 |
Why?
|
| Sequence Analysis | 1 | 2015 | 256 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2014 | 2916 | 0.120 |
Why?
|
| Odds Ratio | 4 | 2020 | 9849 | 0.120 |
Why?
|
| Prognosis | 13 | 2019 | 29060 | 0.120 |
Why?
|
| Ki-67 Antigen | 1 | 2016 | 644 | 0.120 |
Why?
|
| Video Recording | 1 | 2019 | 949 | 0.120 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 346 | 0.120 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2014 | 174 | 0.120 |
Why?
|
| Alkaptonuria | 1 | 1993 | 13 | 0.120 |
Why?
|
| Myocarditis | 2 | 2016 | 771 | 0.120 |
Why?
|
| Hemodynamics | 4 | 2020 | 4196 | 0.120 |
Why?
|
| Diaphyses | 1 | 2013 | 65 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2016 | 2504 | 0.120 |
Why?
|
| Genes, Regulator | 2 | 1991 | 378 | 0.120 |
Why?
|
| Nervous System Malformations | 1 | 2015 | 247 | 0.120 |
Why?
|
| Pancreas | 1 | 2020 | 1687 | 0.120 |
Why?
|
| Endocardial Cushions | 1 | 2013 | 13 | 0.120 |
Why?
|
| Rare Diseases | 1 | 2018 | 553 | 0.110 |
Why?
|
| Microfilament Proteins | 2 | 2011 | 1152 | 0.110 |
Why?
|
| Gene Targeting | 3 | 2014 | 880 | 0.110 |
Why?
|
| Eye Proteins | 2 | 2008 | 645 | 0.110 |
Why?
|
| Heart Septal Defects | 1 | 1994 | 192 | 0.110 |
Why?
|
| Organogenesis | 1 | 2014 | 222 | 0.110 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 1992 | 15 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 1988 | 0.110 |
Why?
|
| Health Education | 1 | 2019 | 1056 | 0.110 |
Why?
|
| Family Health | 6 | 2016 | 1281 | 0.110 |
Why?
|
| Genes, Mitochondrial | 1 | 2012 | 61 | 0.110 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 128 | 0.110 |
Why?
|
| Information Dissemination | 3 | 2017 | 1099 | 0.110 |
Why?
|
| Patient Participation | 2 | 2019 | 1457 | 0.110 |
Why?
|
| Chickens | 5 | 2018 | 865 | 0.110 |
Why?
|
| Chromosome Disorders | 3 | 2013 | 514 | 0.110 |
Why?
|
| Genetics, Population | 2 | 2022 | 934 | 0.110 |
Why?
|
| Streptococcus pyogenes | 1 | 2014 | 289 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 1887 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 2088 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 1157 | 0.100 |
Why?
|
| Osteopontin | 1 | 2013 | 294 | 0.100 |
Why?
|
| Genetic Structures | 1 | 2011 | 12 | 0.100 |
Why?
|
| Protein Folding | 2 | 2014 | 840 | 0.100 |
Why?
|
| Databases, Genetic | 3 | 2017 | 1783 | 0.100 |
Why?
|
| Stroke Volume | 5 | 2018 | 5006 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2505 | 0.100 |
Why?
|
| Endonucleases | 1 | 2014 | 380 | 0.100 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2011 | 65 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 6539 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 1998 | 804 | 0.100 |
Why?
|
| Science | 1 | 2014 | 241 | 0.100 |
Why?
|
| Research Report | 1 | 2015 | 355 | 0.100 |
Why?
|
| Repressor Proteins | 4 | 2023 | 3024 | 0.100 |
Why?
|
| Action Potentials | 3 | 2017 | 1806 | 0.100 |
Why?
|
| Calcium Chloride | 2 | 2001 | 77 | 0.100 |
Why?
|
| Aneurysm, Ruptured | 1 | 2016 | 452 | 0.100 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2013 | 314 | 0.100 |
Why?
|
| Fetal Heart | 1 | 2013 | 276 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2005 | 473 | 0.100 |
Why?
|
| Risk Factors | 12 | 2020 | 72296 | 0.100 |
Why?
|
| Mothers | 1 | 2022 | 2165 | 0.100 |
Why?
|
| Research Design | 3 | 2014 | 5984 | 0.100 |
Why?
|
| Cell Count | 1 | 2015 | 1856 | 0.100 |
Why?
|
| Ultrasonography | 7 | 2014 | 5984 | 0.100 |
Why?
|
| Actins | 9 | 2006 | 2121 | 0.100 |
Why?
|
| Muscular Dystrophies | 1 | 2013 | 393 | 0.100 |
Why?
|
| SOS1 Protein | 1 | 2010 | 41 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2023 | 2962 | 0.090 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2023 | 195 | 0.090 |
Why?
|
| Pressure | 4 | 2019 | 1203 | 0.090 |
Why?
|
| Registries | 5 | 2020 | 8091 | 0.090 |
Why?
|
| Cell Division | 1 | 2018 | 4569 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2012 | 670 | 0.090 |
Why?
|
| Age Factors | 11 | 2019 | 18373 | 0.090 |
Why?
|
| Lipoproteins | 3 | 2003 | 878 | 0.090 |
Why?
|
| Muscle, Skeletal | 7 | 2020 | 4925 | 0.090 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 451 | 0.090 |
Why?
|
| Parathyroid Glands | 4 | 1995 | 509 | 0.090 |
Why?
|
| Ribose-Phosphate Pyrophosphokinase | 1 | 2010 | 9 | 0.090 |
Why?
|
| Thioredoxins | 1 | 2011 | 213 | 0.090 |
Why?
|
| Apolipoprotein C-III | 1 | 2011 | 202 | 0.090 |
Why?
|
| Cell Line | 8 | 2016 | 16000 | 0.090 |
Why?
|
| DNA Methylation | 2 | 2023 | 4285 | 0.090 |
Why?
|
| Resistin | 1 | 2011 | 170 | 0.090 |
Why?
|
| Genomic Library | 2 | 2009 | 193 | 0.090 |
Why?
|
| Postprandial Period | 1 | 2011 | 292 | 0.090 |
Why?
|
| Necrosis | 2 | 2013 | 1643 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 247 | 0.090 |
Why?
|
| Hypertrophy | 2 | 2022 | 569 | 0.090 |
Why?
|
| Metabolome | 1 | 2016 | 895 | 0.090 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 2009 | 28 | 0.090 |
Why?
|
| Noonan Syndrome | 1 | 2010 | 122 | 0.090 |
Why?
|
| Catecholamines | 2 | 2009 | 387 | 0.090 |
Why?
|
| Pregnancy | 8 | 2022 | 29144 | 0.090 |
Why?
|
| Models, Molecular | 7 | 2017 | 5451 | 0.090 |
Why?
|
| Lipase | 1 | 2011 | 314 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 9 | 3 | 1997 | 535 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2014 | 5181 | 0.090 |
Why?
|
| Myopathies, Nemaline | 1 | 2009 | 72 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 3505 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2013 | 530 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2013 | 1115 | 0.090 |
Why?
|
| Long QT Syndrome | 3 | 1999 | 453 | 0.090 |
Why?
|
| Kinetics | 8 | 2021 | 6476 | 0.090 |
Why?
|
| Chick Embryo | 4 | 2014 | 982 | 0.090 |
Why?
|
| HLA Antigens | 3 | 2020 | 1382 | 0.090 |
Why?
|
| Systems Biology | 1 | 2013 | 469 | 0.080 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1994 | 708 | 0.080 |
Why?
|
| Calcineurin | 4 | 2016 | 226 | 0.080 |
Why?
|
| Lateral Line System | 1 | 2008 | 12 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2015 | 838 | 0.080 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 2001 | 834 | 0.080 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 12356 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum | 4 | 2013 | 158 | 0.080 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2013 | 339 | 0.080 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1018 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2009 | 151 | 0.080 |
Why?
|
| Peptides | 2 | 2011 | 4410 | 0.080 |
Why?
|
| Body Patterning | 2 | 2020 | 626 | 0.080 |
Why?
|
| Human Genome Project | 2 | 2017 | 193 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2018 | 1860 | 0.080 |
Why?
|
| Filtration | 1 | 2009 | 234 | 0.080 |
Why?
|
| Connexins | 3 | 2005 | 357 | 0.080 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2012 | 450 | 0.080 |
Why?
|
| Prospective Studies | 10 | 2019 | 53290 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2864 | 0.080 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 4 | 1995 | 222 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 296 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2019 | 8319 | 0.080 |
Why?
|
| Autistic Disorder | 1 | 2017 | 1185 | 0.080 |
Why?
|
| Open Reading Frames | 3 | 2020 | 811 | 0.080 |
Why?
|
| Primary Health Care | 2 | 2015 | 4557 | 0.080 |
Why?
|
| United States | 15 | 2021 | 69872 | 0.080 |
Why?
|
| Crosses, Genetic | 5 | 2010 | 791 | 0.080 |
Why?
|
| Codon, Nonsense | 2 | 2016 | 281 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 2010 | 1240 | 0.080 |
Why?
|
| Vertigo | 1 | 2009 | 202 | 0.080 |
Why?
|
| Time Factors | 12 | 2018 | 40075 | 0.080 |
Why?
|
| Forelimb | 2 | 2005 | 122 | 0.080 |
Why?
|
| Bacterial Proteins | 2 | 2014 | 3854 | 0.080 |
Why?
|
| Double-Blind Method | 3 | 2021 | 12025 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 2104 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2018 | 1537 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2725 | 0.080 |
Why?
|
| Cell Survival | 2 | 2016 | 5882 | 0.080 |
Why?
|
| Azides | 2 | 1984 | 116 | 0.080 |
Why?
|
| Quinazolines | 2 | 1984 | 1356 | 0.080 |
Why?
|
| Iceland | 2 | 2020 | 183 | 0.070 |
Why?
|
| Actomyosin | 2 | 2005 | 111 | 0.070 |
Why?
|
| Collagen Type I | 1 | 2010 | 592 | 0.070 |
Why?
|
| Eustachian Tube | 1 | 2008 | 91 | 0.070 |
Why?
|
| Ubiquitination | 2 | 2023 | 1012 | 0.070 |
Why?
|
| Patient Preference | 1 | 2014 | 889 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2013 | 1539 | 0.070 |
Why?
|
| Indoles | 1 | 2015 | 1839 | 0.070 |
Why?
|
| Limb Buds | 2 | 2024 | 77 | 0.070 |
Why?
|
| Otitis Media with Effusion | 1 | 2008 | 114 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2023 | 2751 | 0.070 |
Why?
|
| Macular Degeneration | 1 | 1994 | 980 | 0.070 |
Why?
|
| Aorta | 4 | 2016 | 2062 | 0.070 |
Why?
|
| Rats, Inbred SHR | 3 | 2011 | 195 | 0.070 |
Why?
|
| Genetic Markers | 5 | 2014 | 2634 | 0.070 |
Why?
|
| Survival Analysis | 7 | 2018 | 10252 | 0.070 |
Why?
|
| Pheochromocytoma | 1 | 2009 | 337 | 0.070 |
Why?
|
| Calreticulin | 1 | 2007 | 98 | 0.070 |
Why?
|
| Tissue Engineering | 1 | 2016 | 1880 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2019 | 3537 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2010 | 1547 | 0.070 |
Why?
|
| Macrophages | 2 | 2020 | 5660 | 0.070 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 186 | 0.070 |
Why?
|
| Biotransformation | 1 | 2006 | 168 | 0.070 |
Why?
|
| Mice, 129 Strain | 2 | 2019 | 386 | 0.070 |
Why?
|
| Environment | 1 | 2012 | 1123 | 0.070 |
Why?
|
| Fatty Acids | 3 | 2000 | 1809 | 0.070 |
Why?
|
| Yeasts | 1 | 2007 | 284 | 0.070 |
Why?
|
| Drosophila Proteins | 1 | 1995 | 1703 | 0.070 |
Why?
|
| Hair Cells, Auditory | 1 | 2008 | 361 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 411 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 1965 | 0.070 |
Why?
|
| Retrospective Studies | 8 | 2021 | 77460 | 0.070 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2003 | 123 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 838 | 0.070 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2006 | 56 | 0.070 |
Why?
|
| Exercise Therapy | 1 | 2012 | 904 | 0.070 |
Why?
|
| Ear, Middle | 1 | 2008 | 334 | 0.070 |
Why?
|
| Linkage Disequilibrium | 2 | 2011 | 1997 | 0.070 |
Why?
|
| Autopsy | 1 | 2009 | 1020 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 19905 | 0.060 |
Why?
|
| Sirolimus | 2 | 2023 | 1565 | 0.060 |
Why?
|
| RNA-Binding Proteins | 3 | 2020 | 1903 | 0.060 |
Why?
|
| Goals | 1 | 2010 | 707 | 0.060 |
Why?
|
| Fetus | 3 | 2016 | 1880 | 0.060 |
Why?
|
| Lymphocytes | 2 | 1996 | 2617 | 0.060 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2011 | 691 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2012 | 1572 | 0.060 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2005 | 60 | 0.060 |
Why?
|
| Escherichia coli | 3 | 2001 | 4217 | 0.060 |
Why?
|
| Cytokines | 3 | 2017 | 7323 | 0.060 |
Why?
|
| Natriuresis | 1 | 1984 | 124 | 0.060 |
Why?
|
| Blotting, Southern | 3 | 1996 | 803 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3154 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2022 | 1335 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2024 | 2649 | 0.060 |
Why?
|
| Sternum | 1 | 2005 | 177 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2007 | 3848 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2022 | 12721 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2021 | 39052 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8949 | 0.060 |
Why?
|
| Dietary Carbohydrates | 2 | 2000 | 905 | 0.060 |
Why?
|
| Cytoskeleton | 1 | 2009 | 1185 | 0.060 |
Why?
|
| MSX1 Transcription Factor | 3 | 2001 | 53 | 0.060 |
Why?
|
| Pantothenate Kinase-Associated Neurodegeneration | 1 | 2003 | 14 | 0.060 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 2 | 1997 | 139 | 0.060 |
Why?
|
| Mesoderm | 2 | 2024 | 686 | 0.060 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2003 | 27 | 0.060 |
Why?
|
| Mass Screening | 1 | 2019 | 5253 | 0.060 |
Why?
|
| Adipose Tissue | 2 | 2017 | 3280 | 0.060 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 4 | 2013 | 493 | 0.060 |
Why?
|
| Transforming Growth Factors | 1 | 2023 | 76 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 14723 | 0.060 |
Why?
|
| Marfan Syndrome | 2 | 2011 | 240 | 0.060 |
Why?
|
| Adenosine Monophosphate | 1 | 2005 | 275 | 0.060 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2005 | 235 | 0.060 |
Why?
|
| Constriction, Pathologic | 2 | 2019 | 1107 | 0.060 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2009 | 740 | 0.060 |
Why?
|
| Urban Population | 1 | 2011 | 2022 | 0.060 |
Why?
|
| Incidence | 3 | 2019 | 20952 | 0.060 |
Why?
|
| Ramipril | 1 | 2023 | 95 | 0.060 |
Why?
|
| DNA Probes | 4 | 1992 | 560 | 0.060 |
Why?
|
| alpha-Galactosidase | 2 | 2017 | 57 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2014 | 3107 | 0.050 |
Why?
|
| Atrial Function | 2 | 2016 | 107 | 0.050 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 6486 | 0.050 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2023 | 112 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 433 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 115 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2016 | 1730 | 0.050 |
Why?
|
| Elasticity | 4 | 2009 | 657 | 0.050 |
Why?
|
| Blood Pressure | 4 | 2011 | 8551 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2018 | 1066 | 0.050 |
Why?
|
| Cyclosporine | 4 | 2014 | 788 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 906 | 0.050 |
Why?
|
| Obesity | 2 | 2022 | 12746 | 0.050 |
Why?
|
| Molecular Conformation | 3 | 2006 | 562 | 0.050 |
Why?
|
| Protein Precursors | 4 | 1988 | 1154 | 0.050 |
Why?
|
| Societies, Medical | 5 | 2011 | 3743 | 0.050 |
Why?
|
| Microscopy, Electron | 6 | 2007 | 2646 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2022 | 245 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2023 | 496 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
| Structure-Activity Relationship | 4 | 2007 | 3130 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2020 | 35425 | 0.050 |
Why?
|
| Ion Channels | 2 | 1997 | 1056 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
| Collagen | 1 | 2010 | 2688 | 0.050 |
Why?
|
| Vestibular Diseases | 1 | 2004 | 217 | 0.050 |
Why?
|
| Nails, Malformed | 1 | 2001 | 32 | 0.050 |
Why?
|
| Quail | 2 | 2018 | 40 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2009 | 1547 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 2019 | 0.050 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2000 | 20 | 0.050 |
Why?
|
| Cholesterol, Dietary | 2 | 1998 | 231 | 0.050 |
Why?
|
| Transgenes | 3 | 2017 | 1009 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4751 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2014 | 418 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2015 | 3921 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2007 | 555 | 0.050 |
Why?
|
| Apolipoprotein A-II | 1 | 2000 | 39 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2016 | 4446 | 0.050 |
Why?
|
| Automation, Laboratory | 1 | 2021 | 101 | 0.050 |
Why?
|
| Risk | 3 | 2020 | 9688 | 0.050 |
Why?
|
| Retinitis Pigmentosa | 1 | 2004 | 386 | 0.050 |
Why?
|
| Connexin 43 | 2 | 2017 | 207 | 0.050 |
Why?
|
| Binding Sites | 4 | 2020 | 6111 | 0.050 |
Why?
|
| Endotoxins | 1 | 2003 | 527 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 491 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 4463 | 0.050 |
Why?
|
| Ligands | 2 | 2019 | 3282 | 0.050 |
Why?
|
| COS Cells | 2 | 2013 | 1161 | 0.050 |
Why?
|
| Leptospirosis | 1 | 1980 | 29 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2003 | 580 | 0.050 |
Why?
|
| Brain | 5 | 2024 | 26388 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 2542 | 0.050 |
Why?
|
| Genes, Fungal | 1 | 2002 | 455 | 0.050 |
Why?
|
| Gene Deletion | 4 | 2012 | 2751 | 0.050 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 2 | 2009 | 54 | 0.050 |
Why?
|
| Parathyroid Hormone | 2 | 1998 | 1800 | 0.050 |
Why?
|
| Protein Subunits | 3 | 2011 | 959 | 0.050 |
Why?
|
| Crossing Over, Genetic | 1 | 2000 | 95 | 0.050 |
Why?
|
| GTP-Binding Proteins | 2 | 2002 | 970 | 0.040 |
Why?
|
| Spironolactone | 1 | 2023 | 382 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2002 | 199 | 0.040 |
Why?
|
| Medical Records | 1 | 2005 | 1413 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 1998 | 403 | 0.040 |
Why?
|
| Antigens, CD | 3 | 2009 | 4026 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 2002 | 449 | 0.040 |
Why?
|
| Stem Cells | 2 | 2012 | 3567 | 0.040 |
Why?
|
| Transfection | 4 | 2012 | 5895 | 0.040 |
Why?
|
| Singapore | 1 | 2020 | 295 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2200 | 0.040 |
Why?
|
| Atrial Myosins | 1 | 1999 | 3 | 0.040 |
Why?
|
| Heredity | 1 | 2020 | 154 | 0.040 |
Why?
|
| Genetic Techniques | 2 | 2000 | 435 | 0.040 |
Why?
|
| Veins | 1 | 2024 | 770 | 0.040 |
Why?
|
| Autoimmune Diseases | 2 | 2002 | 2134 | 0.040 |
Why?
|
| Logistic Models | 2 | 2014 | 13409 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.040 |
Why?
|
| Apolipoprotein A-I | 1 | 2000 | 281 | 0.040 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2019 | 60 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2021 | 1386 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2022 | 572 | 0.040 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2019 | 91 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2000 | 1202 | 0.040 |
Why?
|
| Risk Assessment | 6 | 2019 | 23336 | 0.040 |
Why?
|
| Bundle of His | 1 | 1999 | 87 | 0.040 |
Why?
|
| Follistatin-Related Proteins | 1 | 2019 | 48 | 0.040 |
Why?
|
| Cholesterol, HDL | 3 | 2000 | 1813 | 0.040 |
Why?
|
| Kidney | 4 | 2017 | 7184 | 0.040 |
Why?
|
| Arteries | 1 | 2024 | 1119 | 0.040 |
Why?
|
| Tooth Abnormalities | 1 | 1998 | 54 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2004 | 1461 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2022 | 412 | 0.040 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 2 | 2013 | 22 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2003 | 769 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2006 | 1195 | 0.040 |
Why?
|
| Multigene Family | 1 | 2002 | 1102 | 0.040 |
Why?
|
| Thyroid Diseases | 1 | 2002 | 379 | 0.040 |
Why?
|
| Ulna | 1 | 1999 | 133 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 15 | 0.040 |
Why?
|
| Cardioplegic Solutions | 1 | 2018 | 118 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2003 | 648 | 0.040 |
Why?
|
| Echocardiography, Doppler | 1 | 2002 | 935 | 0.040 |
Why?
|
| Jews | 2 | 1997 | 385 | 0.040 |
Why?
|
| Mutagenesis | 2 | 2018 | 1264 | 0.040 |
Why?
|
| Bone Development | 1 | 2001 | 483 | 0.040 |
Why?
|
| Starch | 1 | 1998 | 81 | 0.040 |
Why?
|
| Acetylation | 1 | 2021 | 1084 | 0.040 |
Why?
|
| Chromosomes | 1 | 2021 | 596 | 0.040 |
Why?
|
| Viscosity | 3 | 2004 | 328 | 0.040 |
Why?
|
| Gene Library | 2 | 2013 | 1074 | 0.040 |
Why?
|
| Interdisciplinary Communication | 2 | 2015 | 950 | 0.040 |
Why?
|
| Data Collection | 3 | 2013 | 3339 | 0.040 |
Why?
|
| Models, Animal | 2 | 2017 | 2173 | 0.040 |
Why?
|
| Exercise Test | 3 | 2017 | 2073 | 0.040 |
Why?
|
| Muscular Diseases | 2 | 2007 | 555 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 25039 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2010 | 1723 | 0.040 |
Why?
|
| Myocardial Infarction | 2 | 2011 | 11718 | 0.040 |
Why?
|
| Pericytes | 1 | 2020 | 293 | 0.040 |
Why?
|
| Activins | 1 | 2019 | 208 | 0.040 |
Why?
|
| Body Surface Potential Mapping | 1 | 1999 | 238 | 0.040 |
Why?
|
| Arrestins | 1 | 1997 | 74 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2018 | 153 | 0.040 |
Why?
|
| Embryo, Mammalian | 3 | 2008 | 1701 | 0.040 |
Why?
|
| Apocrine Glands | 1 | 1997 | 31 | 0.040 |
Why?
|
| Survival Rate | 4 | 2020 | 12788 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 518 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 1998 | 420 | 0.040 |
Why?
|
| Receptors, Calcium-Sensing | 5 | 1998 | 315 | 0.040 |
Why?
|
| Biopsy | 3 | 2017 | 6755 | 0.040 |
Why?
|
| Endocardium | 1 | 2018 | 263 | 0.040 |
Why?
|
| Cell Movement | 3 | 2019 | 5218 | 0.040 |
Why?
|
| Xenopus | 1 | 2019 | 712 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 2009 | 1620 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1143 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 279 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2004 | 1058 | 0.040 |
Why?
|
| Norepinephrine | 2 | 2009 | 909 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2020 | 936 | 0.040 |
Why?
|
| Denmark | 1 | 2019 | 738 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 529 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1997 | 246 | 0.040 |
Why?
|
| Reference Values | 3 | 2018 | 4982 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 1613 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2014 | 1340 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 15078 | 0.040 |
Why?
|
| Liver | 3 | 1995 | 7475 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2017 | 171 | 0.040 |
Why?
|
| Hypertriglyceridemia | 1 | 2000 | 293 | 0.040 |
Why?
|
| Genitalia | 1 | 1997 | 112 | 0.040 |
Why?
|
| Restriction Mapping | 3 | 1995 | 878 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2015 | 3773 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1998 | 367 | 0.040 |
Why?
|
| Alagille Syndrome | 1 | 1996 | 35 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 3524 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2015 | 1686 | 0.040 |
Why?
|
| Genes, Viral | 1 | 2018 | 718 | 0.040 |
Why?
|
| Causality | 1 | 2023 | 1275 | 0.040 |
Why?
|
| Thinness | 1 | 2000 | 480 | 0.030 |
Why?
|
| Cations | 1 | 1997 | 232 | 0.030 |
Why?
|
| Vestibule, Labyrinth | 1 | 1998 | 235 | 0.030 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1999 | 585 | 0.030 |
Why?
|
| Health Communication | 1 | 2019 | 214 | 0.030 |
Why?
|
| Workflow | 1 | 2021 | 847 | 0.030 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1995 | 27 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2017 | 329 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2017 | 209 | 0.030 |
Why?
|
| Catheter Ablation | 4 | 2016 | 2758 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1998 | 456 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2017 | 435 | 0.030 |
Why?
|
| Apoptosis | 2 | 2013 | 9724 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 1998 | 246 | 0.030 |
Why?
|
| Kallmann Syndrome | 1 | 1997 | 140 | 0.030 |
Why?
|
| Ribosomes | 1 | 2019 | 500 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 535 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1423 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 1999 | 544 | 0.030 |
Why?
|
| Israel | 2 | 2014 | 796 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 2076 | 0.030 |
Why?
|
| Epithelium | 1 | 2020 | 1679 | 0.030 |
Why?
|
| Histocompatibility Antigens | 1 | 1977 | 471 | 0.030 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2000 | 373 | 0.030 |
Why?
|
| Magnesium | 2 | 2010 | 813 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 4839 | 0.030 |
Why?
|
| Cilia | 1 | 2019 | 466 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2003 | 2008 | 0.030 |
Why?
|
| Myositis, Inclusion Body | 1 | 1997 | 147 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 1977 | 169 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2016 | 299 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 1996 | 286 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 2 | 2010 | 874 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15535 | 0.030 |
Why?
|
| Lipoproteins, VLDL | 3 | 2003 | 201 | 0.030 |
Why?
|
| Adipokines | 1 | 2017 | 320 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2020 | 1355 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7882 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2015 | 194 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 1213 | 0.030 |
Why?
|
| Bone Diseases, Developmental | 1 | 1995 | 130 | 0.030 |
Why?
|
| Hair | 1 | 1998 | 481 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 634 | 0.030 |
Why?
|
| Macromolecular Substances | 3 | 1995 | 1454 | 0.030 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2003 | 272 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6364 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2016 | 328 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1997 | 707 | 0.030 |
Why?
|
| Prazosin | 2 | 1984 | 96 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1996 | 250 | 0.030 |
Why?
|
| Inclusion Bodies | 1 | 1996 | 279 | 0.030 |
Why?
|
| Uncertainty | 1 | 2019 | 735 | 0.030 |
Why?
|
| Interleukin-2 | 2 | 1999 | 1904 | 0.030 |
Why?
|
| Family | 2 | 2019 | 3147 | 0.030 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1998 | 357 | 0.030 |
Why?
|
| China | 1 | 2020 | 2245 | 0.030 |
Why?
|
| Ventricular Function | 2 | 2004 | 415 | 0.030 |
Why?
|
| London | 1 | 2014 | 233 | 0.030 |
Why?
|
| 5' Flanking Region | 1 | 2014 | 31 | 0.030 |
Why?
|
| Introns | 2 | 1997 | 992 | 0.030 |
Why?
|
| Lebanon | 1 | 2015 | 229 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7282 | 0.030 |
Why?
|
| Triglycerides | 5 | 2003 | 2453 | 0.030 |
Why?
|
| Hippocampus | 2 | 1997 | 3675 | 0.030 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 1993 | 13 | 0.030 |
Why?
|
| Chromosome Aberrations | 2 | 1999 | 1813 | 0.030 |
Why?
|
| Codon, Initiator | 1 | 2014 | 52 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1996 | 338 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 2 | 2001 | 438 | 0.030 |
Why?
|
| Isometric Contraction | 2 | 2004 | 143 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2021 | 1151 | 0.030 |
Why?
|
| Executive Function | 1 | 2023 | 1364 | 0.030 |
Why?
|
| Carbohydrates | 1 | 1996 | 394 | 0.030 |
Why?
|
| Cholesterol, LDL | 2 | 2021 | 2355 | 0.030 |
Why?
|
| Spain | 1 | 2015 | 465 | 0.030 |
Why?
|
| Patient Selection | 2 | 2018 | 4216 | 0.030 |
Why?
|
| Iron | 1 | 2022 | 1774 | 0.030 |
Why?
|
| Myositis | 1 | 2016 | 251 | 0.030 |
Why?
|
| Protein Binding | 4 | 2017 | 9384 | 0.030 |
Why?
|
| Recombination, Genetic | 3 | 2000 | 1586 | 0.030 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2013 | 47 | 0.030 |
Why?
|
| Adipocytes | 1 | 2020 | 1185 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 1996 | 320 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 1996 | 327 | 0.030 |
Why?
|
| Defibrillators | 1 | 2013 | 37 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 2110 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 94 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1184 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2007 | 3702 | 0.030 |
Why?
|
| Genes, Developmental | 1 | 2013 | 40 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 625 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2013 | 118 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 1549 | 0.030 |
Why?
|
| Documentation | 1 | 2019 | 871 | 0.030 |
Why?
|
| Hypocalcemia | 1 | 1994 | 191 | 0.030 |
Why?
|
| Kidney Calculi | 1 | 1998 | 465 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2013 | 147 | 0.030 |
Why?
|
| Myoblasts, Skeletal | 1 | 2013 | 76 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2013 | 110 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1993 | 1801 | 0.030 |
Why?
|
| Ribonucleases | 1 | 1994 | 287 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 1994 | 473 | 0.030 |
Why?
|
| Atrioventricular Node | 2 | 2007 | 182 | 0.030 |
Why?
|
| Breast | 2 | 1999 | 1970 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2014 | 294 | 0.030 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2013 | 57 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 1984 | 1157 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2003 | 1414 | 0.030 |
Why?
|
| Arginine | 3 | 2004 | 944 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 1992 | 278 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1995 | 1185 | 0.030 |
Why?
|
| Thalidomide | 1 | 1997 | 890 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2327 | 0.030 |
Why?
|
| Anaerobiosis | 1 | 2011 | 140 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 1995 | 995 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2010 | 1525 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1984 | 2255 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2003 | 845 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1851 | 0.030 |
Why?
|
| Laminin | 1 | 1993 | 419 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 1783 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 280 | 0.030 |
Why?
|
| Pacemaker, Artificial | 1 | 2017 | 816 | 0.020 |
Why?
|
| Forecasting | 1 | 2001 | 2951 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2002 | 1887 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 551 | 0.020 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 126 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2015 | 772 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2015 | 881 | 0.020 |
Why?
|
| Health | 1 | 2014 | 394 | 0.020 |
Why?
|
| Disease | 1 | 2017 | 680 | 0.020 |
Why?
|
| Papillary Muscles | 2 | 2004 | 203 | 0.020 |
Why?
|
| Inservice Training | 1 | 2014 | 392 | 0.020 |
Why?
|
| Lipids | 1 | 2022 | 3307 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2011 | 72 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2014 | 249 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1939 | 0.020 |
Why?
|
| Neurons | 3 | 2020 | 9340 | 0.020 |
Why?
|
| Proteome | 1 | 2021 | 1798 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 1997 | 1178 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2018 | 7730 | 0.020 |
Why?
|
| Ethylnitrosourea | 1 | 2010 | 51 | 0.020 |
Why?
|
| Ohio | 1 | 2011 | 337 | 0.020 |
Why?
|
| South Africa | 1 | 2016 | 1731 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 2013 | 538 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1996 | 582 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2014 | 674 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2014 | 1802 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1997 | 1206 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 1995 | 783 | 0.020 |
Why?
|
| Radioimmunoassay | 2 | 1988 | 919 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 1106 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2010 | 164 | 0.020 |
Why?
|
| Electric Countershock | 1 | 2013 | 534 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 8432 | 0.020 |
Why?
|
| Cross-Over Studies | 3 | 2003 | 2029 | 0.020 |
Why?
|
| Species Specificity | 1 | 2014 | 2478 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 2 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Receptors, Melanocortin | 1 | 2009 | 25 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 504 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 2003 | 5524 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 11726 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2009 | 235 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2018 | 63107 | 0.020 |
Why?
|
| Proline | 2 | 2003 | 458 | 0.020 |
Why?
|
| Heart-Assist Devices | 1 | 2020 | 1195 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 4479 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2009 | 51 | 0.020 |
Why?
|
| Hypertension | 1 | 2009 | 8479 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2013 | 965 | 0.020 |
Why?
|
| Gadolinium | 1 | 2014 | 952 | 0.020 |
Why?
|
| Placenta | 1 | 1998 | 1699 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 1680 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2009 | 236 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 894 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2009 | 129 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 767 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2009 | 331 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2009 | 142 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 1128 | 0.020 |
Why?
|
| Confidentiality | 1 | 2013 | 612 | 0.020 |
Why?
|
| Lysine | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 840 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2009 | 214 | 0.020 |
Why?
|
| Ouabain | 1 | 1988 | 264 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3690 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 592 | 0.020 |
Why?
|
| Disclosure | 1 | 2014 | 736 | 0.020 |
Why?
|
| Glutamine | 2 | 2004 | 579 | 0.020 |
Why?
|
| Inflammation | 3 | 2003 | 10637 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 1970 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2012 | 784 | 0.020 |
Why?
|
| Ovalbumin | 2 | 2003 | 719 | 0.020 |
Why?
|
| Skeleton | 1 | 2007 | 30 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3508 | 0.020 |
Why?
|
| Isoleucine | 1 | 2007 | 112 | 0.020 |
Why?
|
| Cholesterol | 2 | 2011 | 2919 | 0.020 |
Why?
|
| Cause of Death | 1 | 2018 | 3582 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 1912 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2000 | 3966 | 0.020 |
Why?
|
| Substrate Cycling | 1 | 2007 | 8 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 712 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 1151 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2760 | 0.020 |
Why?
|
| Biological Specimen Banks | 1 | 2013 | 711 | 0.020 |
Why?
|
| Drosophila | 1 | 1995 | 1491 | 0.020 |
Why?
|
| Glycolysis | 1 | 2011 | 829 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2016 | 2499 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 768 | 0.020 |
Why?
|
| Tibia | 1 | 2013 | 1077 | 0.020 |
Why?
|
| Pyrazines | 1 | 2013 | 1230 | 0.020 |
Why?
|
| Probability | 1 | 1993 | 2506 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2011 | 775 | 0.020 |
Why?
|
| Tetracycline | 1 | 2007 | 214 | 0.020 |
Why?
|
| Antibodies | 2 | 2013 | 2460 | 0.020 |
Why?
|
| Neomycin | 2 | 1997 | 88 | 0.020 |
Why?
|
| Genetic Code | 1 | 1987 | 154 | 0.020 |
Why?
|
| Rabbits | 3 | 2008 | 4894 | 0.020 |
Why?
|
| Protein Stability | 1 | 2009 | 556 | 0.020 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2009 | 281 | 0.020 |
Why?
|
| Cytoplasmic Granules | 2 | 1986 | 610 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2022 | 9145 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2018 | 2531 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2007 | 211 | 0.020 |
Why?
|
| Health Promotion | 1 | 2019 | 2205 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2016 | 2108 | 0.020 |
Why?
|
| Brazil | 1 | 2011 | 1270 | 0.020 |
Why?
|
| Acetyltransferases | 1 | 1988 | 234 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15297 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 279 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 4459 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 6994 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 2 | 2002 | 964 | 0.020 |
Why?
|
| Optical Tweezers | 1 | 2007 | 79 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 1443 | 0.020 |
Why?
|
| Europe | 2 | 2009 | 3338 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 644 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2008 | 278 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2887 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1990 | 1504 | 0.020 |
Why?
|
| Telemetry | 1 | 2007 | 207 | 0.020 |
Why?
|
| Mitochondrial Myopathies | 1 | 2006 | 47 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2013 | 881 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2017 | 2148 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2014 | 1491 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 372 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2001 | 1085 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1991 | 1063 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 3020 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 474 | 0.020 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2006 | 119 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4933 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 661 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2013 | 980 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 1990 | 971 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2005 | 203 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 185 | 0.020 |
Why?
|
| Visual Acuity | 1 | 1994 | 2530 | 0.020 |
Why?
|
| Natriuretic Agents | 1 | 1984 | 25 | 0.020 |
Why?
|
| Leadership | 1 | 2014 | 1357 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2007 | 4222 | 0.020 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2005 | 41 | 0.020 |
Why?
|
| Carpal Bones | 1 | 2005 | 77 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 2086 | 0.020 |
Why?
|
| Sex Factors | 3 | 2008 | 10400 | 0.020 |
Why?
|
| Tacrolimus | 2 | 2000 | 743 | 0.020 |
Why?
|
| Venezuela | 1 | 2004 | 73 | 0.020 |
Why?
|
| Propylthiouracil | 1 | 2004 | 69 | 0.020 |
Why?
|
| Communication | 1 | 2018 | 3750 | 0.020 |
Why?
|
| PAX9 Transcription Factor | 1 | 2003 | 13 | 0.020 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2005 | 95 | 0.020 |
Why?
|
| Cell Membrane | 2 | 1984 | 3749 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2020 | 4369 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 3338 | 0.010 |
Why?
|
| Photolysis | 1 | 1984 | 92 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 1997 | 3587 | 0.010 |
Why?
|
| Dyneins | 1 | 2004 | 123 | 0.010 |
Why?
|
| Procainamide | 1 | 2003 | 61 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 1775 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2008 | 711 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2007 | 570 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 2004 | 420 | 0.010 |
Why?
|
| Disease Management | 1 | 2014 | 2460 | 0.010 |
Why?
|
| Biological Transport | 2 | 2000 | 2120 | 0.010 |
Why?
|
| Constriction | 1 | 2003 | 181 | 0.010 |
Why?
|
| Muscle Strength | 1 | 2008 | 592 | 0.010 |
Why?
|
| Epilepsy | 1 | 2019 | 3310 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1984 | 462 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2009 | 1073 | 0.010 |
Why?
|
| Diagnosis, Differential | 3 | 2005 | 12961 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 758 | 0.010 |
Why?
|
| Serum Amyloid A Protein | 1 | 2003 | 121 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 1247 | 0.010 |
Why?
|
| Retina | 1 | 1994 | 2616 | 0.010 |
Why?
|
| Motor Activity | 1 | 2013 | 2715 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2014 | 2921 | 0.010 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2007 | 783 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2013 | 2948 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2003 | 149 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1984 | 2186 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1984 | 302 | 0.010 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 93 | 0.010 |
Why?
|
| Gestational Age | 1 | 1991 | 3493 | 0.010 |
Why?
|
| Stroke | 2 | 2020 | 9981 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5135 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2003 | 139 | 0.010 |
Why?
|
| Nucleotides | 1 | 1985 | 464 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2012 | 2926 | 0.010 |
Why?
|
| Potassium | 2 | 2002 | 1336 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2011 | 2575 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2002 | 89 | 0.010 |
Why?
|
| Myosin Light Chains | 1 | 2002 | 121 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1572 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1997 | 10183 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 595 | 0.010 |
Why?
|
| Anthropometry | 1 | 2006 | 1350 | 0.010 |
Why?
|
| Interferon-gamma | 2 | 2003 | 3207 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 464 | 0.010 |
Why?
|
| Dietary Fats | 2 | 2000 | 2016 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1988 | 1951 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2003 | 437 | 0.010 |
Why?
|
| Minoxidil | 1 | 2000 | 33 | 0.010 |
Why?
|
| Resuscitation | 1 | 1985 | 658 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 6313 | 0.010 |
Why?
|
| Contrast Media | 1 | 2014 | 5300 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 1420 | 0.010 |
Why?
|
| Curriculum | 1 | 2014 | 3605 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2005 | 602 | 0.010 |
Why?
|
| Phosphates | 1 | 2004 | 785 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2002 | 240 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 13991 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2019 | 6882 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2003 | 546 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2003 | 844 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 2001 | 215 | 0.010 |
Why?
|
| Lamins | 1 | 1999 | 36 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3841 | 0.010 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1980 | 138 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2013 | 6194 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8385 | 0.010 |
Why?
|
| Oocytes | 2 | 1995 | 1188 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2003 | 1590 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 3611 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 2002 | 468 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2000 | 402 | 0.010 |
Why?
|
| Paralysis | 1 | 2001 | 247 | 0.010 |
Why?
|
| Cattle | 2 | 1995 | 3922 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 873 | 0.010 |
Why?
|
| Mice, Congenic | 1 | 1999 | 99 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 3922 | 0.010 |
Why?
|
| Down-Regulation | 2 | 2001 | 3001 | 0.010 |
Why?
|
| Nitrogen | 2 | 1997 | 344 | 0.010 |
Why?
|
| Body Weight | 2 | 2002 | 4671 | 0.010 |
Why?
|
| Patients | 1 | 1985 | 900 | 0.010 |
Why?
|
| Audiometry | 1 | 1999 | 241 | 0.010 |
Why?
|
| Hepatitis, Alcoholic | 1 | 1980 | 103 | 0.010 |
Why?
|
| Sheep | 1 | 2001 | 1437 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 895 | 0.010 |
Why?
|
| Adenosine | 1 | 2003 | 825 | 0.010 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1998 | 39 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2014 | 4687 | 0.010 |
Why?
|
| Electromyography | 1 | 2003 | 1379 | 0.010 |
Why?
|
| Physical Conditioning, Animal | 1 | 2001 | 354 | 0.010 |
Why?
|
| Melanoma | 1 | 2016 | 5511 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 9955 | 0.010 |
Why?
|
| Glucagon | 1 | 2000 | 533 | 0.010 |
Why?
|
| Suppuration | 1 | 1997 | 56 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 719 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8300 | 0.010 |
Why?
|
| Calorimetry | 1 | 1997 | 126 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 1868 | 0.010 |
Why?
|
| Weight Loss | 2 | 2001 | 2625 | 0.010 |
Why?
|
| Afghanistan | 1 | 1997 | 81 | 0.010 |
Why?
|
| Iraq | 1 | 1997 | 92 | 0.010 |
Why?
|
| Leg Ulcer | 1 | 1997 | 69 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2011 | 3864 | 0.010 |
Why?
|
| Spermine | 1 | 1997 | 70 | 0.010 |
Why?
|
| Ethanol | 1 | 2003 | 1342 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 7914 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 655 | 0.010 |
Why?
|
| Exercise | 1 | 2013 | 5615 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1997 | 192 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6621 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 2251 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 1998 | 331 | 0.010 |
Why?
|
| Persia | 1 | 1996 | 6 | 0.010 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 1996 | 70 | 0.010 |
Why?
|
| Immunization | 1 | 2001 | 1256 | 0.010 |
Why?
|
| Retroviridae | 1 | 1999 | 914 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3084 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1997 | 573 | 0.010 |
Why?
|
| Mitogens | 1 | 1996 | 232 | 0.010 |
Why?
|
| France | 1 | 1997 | 517 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1997 | 594 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2006 | 2212 | 0.010 |
Why?
|
| Eggs | 1 | 1996 | 184 | 0.010 |
Why?
|
| Nitrogen Fixation | 1 | 1975 | 60 | 0.010 |
Why?
|
| Tetany | 1 | 1994 | 12 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2003 | 1826 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1995 | 291 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1994 | 114 | 0.010 |
Why?
|
| Bile | 1 | 1995 | 299 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 206 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1998 | 10943 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2000 | 6254 | 0.010 |
Why?
|
| Chimera | 1 | 1996 | 485 | 0.010 |
Why?
|
| Insulin | 2 | 2000 | 6582 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 1999 | 1879 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 4251 | 0.010 |
Why?
|
| Dietary Fiber | 1 | 1998 | 760 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1999 | 1117 | 0.010 |
Why?
|
| Inpatients | 1 | 1985 | 2518 | 0.010 |
Why?
|
| Fasting | 1 | 2000 | 1592 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1996 | 854 | 0.010 |
Why?
|
| Perfusion | 1 | 1998 | 1360 | 0.010 |
Why?
|
| Luciferases | 1 | 1995 | 733 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 6489 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1996 | 695 | 0.010 |
Why?
|
| Klebsiella pneumoniae | 1 | 1975 | 251 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1998 | 792 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1995 | 288 | 0.010 |
Why?
|
| Eating | 1 | 2000 | 1536 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 1996 | 413 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 6773 | 0.010 |
Why?
|
| Radiography | 1 | 2003 | 7023 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 1997 | 824 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1997 | 1460 | 0.010 |
Why?
|
| Solubility | 1 | 1994 | 1088 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1997 | 1767 | 0.010 |
Why?
|
| Canada | 1 | 1997 | 2065 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2003 | 3778 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1992 | 258 | 0.010 |
Why?
|
| HIV Infections | 1 | 1997 | 16715 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1995 | 1899 | 0.010 |
Why?
|
| Polymers | 1 | 1998 | 1621 | 0.010 |
Why?
|
| Dogs | 1 | 1995 | 3912 | 0.010 |
Why?
|
| Immunity | 1 | 1977 | 1014 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1994 | 957 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 7785 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1990 | 318 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 427 | 0.010 |
Why?
|
| Energy Intake | 1 | 1998 | 2148 | 0.010 |
Why?
|
| Acute Disease | 1 | 1980 | 7147 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 3799 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1996 | 1782 | 0.010 |
Why?
|
| Calcimycin | 1 | 1988 | 222 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1998 | 6459 | 0.010 |
Why?
|
| Body Composition | 1 | 1997 | 2402 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 3759 | 0.000 |
Why?
|
| Isoelectric Focusing | 1 | 1987 | 181 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1987 | 349 | 0.000 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1985 | 115 | 0.000 |
Why?
|
| Protein Sorting Signals | 1 | 1986 | 281 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1997 | 4424 | 0.000 |
Why?
|
| Immune Sera | 1 | 1985 | 641 | 0.000 |
Why?
|
| Maryland | 1 | 1985 | 276 | 0.000 |
Why?
|
| Autoradiography | 1 | 1985 | 745 | 0.000 |
Why?
|
| Chlorides | 1 | 1987 | 667 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1986 | 1799 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 4153 | 0.000 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 3771 | 0.000 |
Why?
|
| Sodium | 1 | 1987 | 1622 | 0.000 |
Why?
|
| Water | 1 | 1986 | 1395 | 0.000 |
Why?
|
| Diet | 1 | 1996 | 7937 | 0.000 |
Why?
|
| Nitrosoguanidines | 1 | 1975 | 8 | 0.000 |
Why?
|
| Enzyme Repression | 1 | 1975 | 32 | 0.000 |
Why?
|
| Amino Alcohols | 1 | 1975 | 16 | 0.000 |
Why?
|
| Nitrogenase | 1 | 1975 | 36 | 0.000 |
Why?
|
| Mutagens | 1 | 1975 | 168 | 0.000 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1975 | 170 | 0.000 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1975 | 205 | 0.000 |
Why?
|
| Electron Transport | 1 | 1975 | 211 | 0.000 |
Why?
|
| Histidine | 1 | 1975 | 313 | 0.000 |
Why?
|
| Transduction, Genetic | 1 | 1975 | 913 | 0.000 |
Why?
|